VC fund profile · evidence-aware directory data
Yosemite Fund II stages, portfolio and investment profile
Yosemite Fund II closed at $350M, as Reed Jobs told Fortune on November 4, 2026. January's $200M first close is included in this total; it is not an extra round. Named LPs include Amgen, AbbVie, MIT, Memorial Sloan Kettering and John Doerr. Exact legal close date and fees undisclosed.
Keep track of Yosemite Fund II
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$100K–$1M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Not recorded
Participates: Not recorded
Sector focus
Not recorded
Geography
San Francisco, USA
Founded Not recorded
Fund size / AUM
Not recorded
A separate fund-size evidence record is not yet available.
Portfolio in our directory
None yet
Linked startup profiles
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.